Agitated saline bubble studies in conjunction with echocardiography, in particular transesophageal echocardiography, are currently the principal means in the diagnosis of patent foramen ovale (PFO). We describe techniques and guidelines for the detection and exclusion of a PFO. The potential for misinterpretation of these bubble studies exists and therefore, several false positive and false negative scenarios are illustrated and discussed.

Despite the fact that the incidence of cardiac tumors is low, the prompt evaluation and adequate intervention of these is highly important. Although most tumors of the heart are considered histologically benign, there are significant risks associated with these "benign" tumors. These are associated with significant morbidity and mortality due to obstruction of blood flow, alterations of conduction, propagation of arrhythmias, and thromboembolism, depending on their size, location, and nature. With the advent of noninvasive imaging modalities--traditionally echocardiography; but more recently using cross-sectional imaging with cardiac computed tomography and magnetic resonance imaging--cardiac tumors can be optimally assessed providing a greater opportunity for curative treatments by cardiothoracic surgery.

LAD > 4.7 cm via the traditional method can be used to indicate left atrial enlargement. However, a LAD < or = 4.7 cm does not correlate well with the LAVI, and in such patients, extreme caution should be employed when using the LAD to estimate cardiac prognosis.

Cardiac MRI (CMR) is a noninvasive diagnostic tool with comprehensive capabilities similar to that of two-dimensional echocardiography with Doppler. In addition to the ability to evaluate the etiology and severity of pulmonary valve regurgitation (PR), CMR is well designed to serially monitor the impact of the PR on the right ventricle (RV). Importantly, RV dilation and dysfunction is a critical determinate to time surgical intervention. CMR gives the silent RV, suffering from PR, a voice.

No abstract